Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
Greenhalgh J, Bagust A, Boland A, Fleeman N, McLeod C, Dundar Y, Proudlove C, Shaw R
Record ID 32013000637
English
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
http://www.hta.ac.uk/erg/supplements/supplement1303.pdf#nameddest=article08
URL for additional information:
http://www.hta.ac.uk/1778
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Antibodies, Monoclonal, Humanized
- Cetuximab
- Cost-Benefit Analysis
- Neoplasm Metastasis
- Randomized Controlled Trials as Topic
- Antibodies, Monoclonal
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Squamous Cell
- Cyclophosphamide
- Head and Neck Neoplasms
- Neoplasm Recurrence, Local
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.